MSOS 股價展望與 ETF 分析 - 配息·管理費·持股·NAV·RSI·MACD | 美股今日
10月29日 7:44 PM ET（韓國 10/30 08:44）
詳細指標表
| Category | US Equities - Factor & Thematic | Expense | 0.78% | Return% 1Y | -11.76% | Total Holdings | 25 | Perf Week | 0% | Volume | 2,332,158 |
| Asset Type | Equities (Stocks) | AUM | $751M | Return% 3Y | -14.55% | NAV | $4.05 | Perf Month | -9.73% | Avg Volume | 4.73M |
| ETF Type | US Equities | Dividend TTM | - | Return% 5Y | -32.81% | 52W High | -43.72% | Perf Quarter | -3.55% | Rel Volume | 0.49 |
| Active/Passive | Active | Div Gr. 3/5Y | - | Return% 10Y | - | 52W Low | 37.84% | Perf Half Y | -20.16% | Prev Close | $4.05 |
| IPO | 2020/9/2 | Flows% 1M | -6.3% | Return% SI | -25.44% | RSI (14) | 42.18 | Perf YTD | -13.56% | Price | $4.08 |
| Beta | 1.52 | Flows% 3M | -8.49% | Flows% YTD | -6.54% | Flows% 1Y | 2.16% | Perf Year | -9.73% | Volatility(W/M) | 4.12% 4.83% |
| SMA20 | -1.5% | SMA50 | -11.96% | SMA200 | -8.34% | ATR | 0.2 | ||||
AdvisorShares Pure US Cannabis ETF seeks long-term capital appreciation. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.
前 10 大持股占 基金的 42%
TRLV TRULIEVE CANNABIS CORP 9.56% 
GLAS GLASS HOUSE BRANDS INC 0.93% 過去一年中， 屬於中等
較一年最高價低 44%。
成交量低於平時。 相當於平均成交量的49%。
若長期持有 表現不如預期
若 5 年前買入，現在的報酬率為 -84.9%。 同期標普 500 為 +68%。
點擊查看數字
價格 波動非常劇烈
最糟時（2021年2月）下跌了 96%，至今尚未完全恢復。
點擊查看數字
沒有股息
目前還沒有可分配的利潤。
資金小幅流入
最近一年流入了相當於資產 2.2% 的新資金。
點擊查看數字
MSOX AdvisorShares MSOS 2x Daily ETF 45M 
